Eramol’s purpose-built sterile manufacturing facility at the Sevenoaks campus is in the final stages of commissioning and awaiting MHRA inspection. The site is expected to become operational in Q2 2026, subject to regulatory approval. Commissioning began in mid-January, with the “going clean” phase scheduled for late January/early February. Designed to meet EU GMP Annex 1 (2023) standards, the facility will provide aseptic fill-finish and terminal sterilization services for Phase I and II cli...